Trademark Overview

---

On Friday, October 29, 2010, a trademark application was filed for ALLOW- EVALUATION OF ABATACEPT ADMINISTERED SUBCUTANEOUSLY IN ADULTS WITH ACTIVE RHEUMATOID ARTHRITIS; IMPACT OF WITHDRAWAL AND REINTRODUCTION ON IMMUNOGENICITY, EFFICACY AND SAFETY with the United States Patent and Trademark Office. The USPTO has given the ALLOW- EVALUATION OF ABATACEPT ADMINISTERED SUBCUTANEOUSLY IN ADULTS WITH ACTIVE RHEUMATOID ARTHRITIS; IMPACT OF WITHDRAWAL AND REINTRODUCTION ON IMMUNOGENICITY, EFFICACY AND SAFETY trademark a serial number of 85164758. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 13, 2014. This trademark is owned by Bristol-Myers Squibb Company. The ALLOW- EVALUATION OF ABATACEPT ADMINISTERED SUBCUTANEOUSLY IN ADULTS WITH ACTIVE RHEUMATOID ARTHRITIS; IMPACT OF WITHDRAWAL AND REINTRODUCTION ON IMMUNOGENICITY, EFFICACY AND SAFETY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use

General Information

---

Serial Number	85164758
Word Mark	ALLOW- EVALUATION OF ABATACEPT ADMINISTERED SUBCUTANEOUSLY IN ADULTS WITH ACTIVE RHEUMATOID ARTHRITIS; IMPACT OF WITHDRAWAL AND REINTRODUCTION ON IMMUNOGENICITY, EFFICACY AND SAFETY
Filing Date	Friday, October 29, 2010
Status	606 - ABANDONED - NO STATEMENT OF USE FILED
Status Date	Monday, January 13, 2014
Registration Number	0000000
Registration Date	NOT AVAILABLE
Mark Drawing	4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition Date	Tuesday, April 12, 2011

Trademark Statements

---

Goods and Services

Medical and scientific research, namely, conducting clinical trials and clinical studies relating to pharmaceutical preparations for human use

Classification Information

---

International Class	042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes	100, 101
Class Status Code	6 - Active
Class Status Date	Wednesday, November 3, 2010
Primary Code	042
First Use Anywhere Date	NOT AVAILABLE
First Use In Commerce Date	NOT AVAILABLE

Trademark Owner History

---

Party Name	Bristol-Myers Squibb Company
Party Type	20 - Owner at Publication
Legal Entity Type	03 - Corporation
Address	New York, NY 10154

---

Party Name	Bristol-Myers Squibb Company
Party Type	10 - Original Applicant
Legal Entity Type	03 - Corporation
Address	New York, NY 10154

Trademark Events

---

Event Date	Event Description
Monday, January 13, 2014	ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 13, 2014	ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 9, 2013	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 8, 2013	EXTENSION 4 GRANTED
Friday, June 7, 2013	EXTENSION 4 FILED
Friday, June 7, 2013	TEAS EXTENSION RECEIVED
Tuesday, March 12, 2013	TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 21, 2012	NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, November 20, 2012	EXTENSION 3 GRANTED
Thursday, November 15, 2012	EXTENSION 3 FILED
Thursday, November 15, 2012	TEAS EXTENSION RECEIVED
Friday, May 18, 2012	NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Thursday, May 17, 2012	EXTENSION 2 GRANTED
Wednesday, April 25, 2012	EXTENSION 2 FILED
Wednesday, May 16, 2012	CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 25, 2012	TEAS EXTENSION RECEIVED
Wednesday, October 26, 2011	NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Monday, October 24, 2011	EXTENSION 1 GRANTED
Monday, October 24, 2011	EXTENSION 1 FILED
Monday, October 24, 2011	TEAS EXTENSION RECEIVED
Tuesday, June 7, 2011	NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 19, 2011	ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 19, 2011	TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 12, 2011	PUBLISHED FOR OPPOSITION
Wednesday, March 23, 2011	NOTICE OF PUBLICATION
Thursday, March 10, 2011	LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, March 10, 2011	ASSIGNED TO LIE
Tuesday, February 15, 2011	APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 15, 2011	EXAMINER'S AMENDMENT MAILED
Tuesday, February 15, 2011	EXAMINER'S AMENDMENT ENTERED
Tuesday, February 15, 2011	EXAMINERS AMENDMENT -WRITTEN
Tuesday, February 8, 2011	ASSIGNED TO EXAMINER
Wednesday, November 3, 2010	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, November 2, 2010	NEW APPLICATION ENTERED IN TRAM

Related Keywords

---

withdrawal impact reintroduction immunogenicity safety efficacy arthritis rheumatoid abatacept evaluation clinical relating pharmaceutical preparations human studies trials research namely conducting